PEN Q2 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$339M+13.4% YoY

Gross Profit

$224M66.0% margin

Operating Income

$41M12.0% margin

Net Income

$45M13.3% margin

EPS (Diluted)

$1.15

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$29M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$381M

Stockholders' Equity

$1.3B

Cash & Equivalents

$422M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$339M	$299M	+13.4%
Gross Profit	$224M	$163M	+37.6%
Operating Income	$41M	-$81M	+150.4%
Net Income	$45M	-$60M	+175.2%

Geographic Segments

UNITED STATES

$261M77%

Other Non-US

$79M23%